Phase II study of pirarubicin in advanced non-small cell lung cancer

Eur J Cancer Clin Oncol. 1989 Oct;25(10):1507-8. doi: 10.1016/0277-5379(89)90113-2.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged

Substances

  • Doxorubicin
  • pirarubicin